AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
India: FIPB holds back Wockhardt plan.
NEW DELHI, Nov. 30 THE Foreign Investment Promotion Board (FIPB) has deferred for the second time its decision on Wockhardt Ltd's proposal to buy out the 50 per cent foreign stake held by Rhein Biotech GmbH in the joint venture company Wockhardt Rhein Biopharm Ltd, following the objections to the proposal raised by the Department of Biotechnology.
The Department of Biotechnology has informed the FIPB that there are several interconnected issues relating to the application filed by Indo-German joint venture company that had to be examined.
These include manufacture of recombinant drugs without necessary approvals and manufacture of licensable drugs without …
-
- NACHRICHTEN FUER AUSSENHANDEL: Rhein Biopharm discontinues joint venture in...
-
News wire article from: Chemical Business Newsbase
September 12, 2001
700+ words
-
- BUSINESS LINE: FIPB holds back Wockhardt plan.
-
News wire article from: Chemical Business Newsbase
December 1, 2001
700+ words
-
- FIPB HOLDS BACK WOCKHARDT PLAN (on objections raised by the Department of...
-
Magazine article from: India Business Insight
December 1, 2001
700+ words
-
- Wockhardt recast of Rhein Biotech venture complete.
-
News wire article from: Business Line
March 27, 2002
700+ words
-
- WOCKHARDT BUYS OUT RHEIN FROM JV (Wockhardt gets Rhein's technology to...
-
Magazine article from: India Business Insight
March 27, 2002
700+ words
